Rockwell Medical reports Q4 2024 financial results

Rockwell Medical, Inc. held its fourth quarter and full year 2024 earnings call on March 20, 2025. The conference began with Heather Hunter, Senior Vice President, welcoming participants and introducing key company leaders. She mentioned that the call would include forward-looking statements about the company’s future. These statements reflect the company's opinions and are subject to risks that might affect the actual results. Heather emphasized that Rockwell Medical is not obligated to update these statements unless required by law. Dr. Mark Strobeck, the company's President and CEO, along with Tim Chole, Chief Commercial Officer, and Jesse Neri, Chief Financial Officer, were also part of the call. They discussed the company's performance and future plans. Investors and analysts on the call included representatives from notable firms such as Rodman & Renshaw and H.C. Wainwright. The call allowed shareholders to gain insights into Rockwell Medical's recent achievements and strategic direction as the company moves forward.